RECURRENT NON-SMALL LUNG CELL CANCER

Clinical trials for RECURRENT NON-SMALL LUNG CELL CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT NON-SMALL LUNG CELL CANCER trials appear

Sign up with your email to follow new studies for RECURRENT NON-SMALL LUNG CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough lung cancers: Triple-Threat treatment tested

Disease control Ongoing

This study is testing a new combination of three drugs for people with advanced non-small cell lung cancer that has spread or come back after standard treatments failed. The goal is to see if mixing an immunotherapy drug, a drug that blocks tumor blood supply, and a chemotherapy …

Matched conditions: RECURRENT NON-SMALL LUNG CELL CANCER

Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control

Last updated Mar 11, 2026 14:53 UTC

RECURRENT NON-SMALL LUNG CELL CANCER

Get alerted when new RECURRENT NON-SMALL LUNG CELL CANCER trials appear

New hope for tough lung cancers: Triple-Threat treatment tested